Stifel Financial
GILD icon

Stifel Financial’s Gilead Sciences GILD Stock Holding History

Stifel Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-300
Closed -$31K – 2343
2014
Q4 		$31K Hold
300
– – ﹤0.01% 2236
2014
Q3 		$34K Hold
300
– – ﹤0.01% 2167
2014
Q2 		$27K Buy
+300
New +$23.4K ﹤0.01% 2166

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Stifel Financial's GILD Position: Q1 2026 in Review

Stifel Financial reduced its Gilead Sciences (GILD) stake by 13% in Q1 2026, selling an estimated $25.8M and leaving 1,202,321 shares worth $168M. The position accounts for 0.15% of the portfolio, ranked #156.

Stifel Financial first reported a position in GILD in Q1 2014 and has held it in 49 quarters since. The position peaked at $170M in Q4 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Stifel Financial held 1,202,321 shares of Gilead Sciences worth $168M as of Q1 2026.
  • Stifel Financial sold 184,349 Gilead Sciences shares in Q1 2026, an estimated $25.8M.
  • Gilead Sciences made up 0.15% of Stifel Financial's portfolio in Q1 2026, its #156 holding.
  • Stifel Financial first reported a position in Gilead Sciences in Q1 2014 and has held it in 49 quarters since.
  • Stifel Financial's Gilead Sciences position peaked at $170M in Q4 2025.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.